Intravenous Sodium Bicarbonate in Treating Patients With Severe Metabolic Acidemia

Affiliations

¹ Medical and Research Services VHAGLA Healthcare System, Los Angeles, CA; UCLA Membrane Biology Laboratory, Los Angeles, CA; Division of Nephrology VHAGLA Healthcare System, Los Angeles, CA; David Geffen School of Medicine, Los Angeles, CA. Electronic address: jkraut@ucla.edu.
² Division of Nephrology, Department of Medicine, St. Elizabeth's Medical Center, Boston, MA; Department of Medicine, Tufts University School of Medicine, Boston, MA. Electronic address: nicolaos.madias@steward.org.

Editorial

Jeffrey A Kraut et al. Am J Kidney Dis. 2019 Apr.

. 2019 Apr;73(4):572-575.

doi: 10.1053/j.ajkd.2018.08.011. Epub 2018 Oct 18.

¹ Medical and Research Services VHAGLA Healthcare System, Los Angeles, CA; UCLA Membrane Biology Laboratory, Los Angeles, CA; Division of Nephrology VHAGLA Healthcare System, Los Angeles, CA; David Geffen School of Medicine, Los Angeles, CA. Electronic address: jkraut@ucla.edu.
² Division of Nephrology, Department of Medicine, St. Elizabeth's Medical Center, Boston, MA; Department of Medicine, Tufts University School of Medicine, Boston, MA. Electronic address: nicolaos.madias@steward.org.

No abstract available

Comment on

Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial.
Jaber S, Paugam C, Futier E, Lefrant JY, Lasocki S, Lescot T, Pottecher J, Demoule A, Ferrandière M, Asehnoune K, Dellamonica J, Velly L, Abback PS, de Jong A, Brunot V, Belafia F, Roquilly A, Chanques G, Muller L, Constantin JM, Bertet H, Klouche K, Molinari N, Jung B; BICAR-ICU Study Group. Jaber S, et al. Lancet. 2018 Jul 7;392(10141):31-40. doi: 10.1016/S0140-6736(18)31080-8. Epub 2018 Jun 14. Lancet. 2018. PMID: 29910040 Clinical Trial.